University College London Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
University of Reading Featured PhD Programmes
"cell" AND "migration"×
10 miles

cell migration PhD Projects, Programs & Scholarships

We have 54 cell migration PhD Projects, Programs & Scholarships

  • "cell" AND "migration" ×
  • clear all
Order by 
Showing 1 to 10 of 54
  Microtubule motors in cell migration and integrin trafficking
  Prof V Allan, Prof P Woodman, Dr P Caswell
Applications accepted all year round

Funding Type

PhD Type

Cell migration is vital for the development and health of multicellular organisms. However, enhanced cell migration is also a hallmark of cancer cells, and contributes greatly to metastasis.
  Syndecan-4 regulates cell migration during healing and cancer through caveolar endocytosis
  Dr M Bass
Applications accepted all year round

Funding Type

PhD Type

Cell migration during wound healing or cancer cell invasion involves responses to multiple factors including extracellular matrix and growth factors.
  Role of lipids in regulating in vivo chemotaxis
  Dr A Renault
Applications accepted all year round

Funding Type

PhD Type

Aberrant cell migration is a critical factor in the progression of many diseases including cancer and atherosclerosis.
  Studying tissue wide coordination of pulsed contractility during morphogenesis in Drosophila
  Research Group: Biomedical Sciences Research Centre
  Dr M Bischoff
Application Deadline: 1 December 2019

Funding Type

PhD Type

During morphogenesis, cells undergo complex behaviours, including cell movement and apical constriction to shape tissues and organs.
  Does fatty acid uptake by oral cancer cells drive metastasis?
  Dr C Murdoch, Dr H Colley
Applications accepted all year round

Funding Type

PhD Type

The cell surface receptor CD36 belongs to a large scavenger receptor family that primarily bind lipid-containing molecules. Until recently their expression was thought to be restricted to macrophages and endothelial cells but recent data suggest that epithelial cancer cells may also express this receptor.
  Adhesion Pathways in Extracellular Matrix Organisation
  Prof J Adams
Applications accepted all year round

Funding Type

PhD Type

The extracellular matrix (ECM) provides structural and mechanical support to tissues and modulates cell phenotype and behaviour in health and disease.
  Unraveling the signal regulation network of cell adhesion, migration, and invasion in podosomes and invadopodia
  Dr C Yu
Applications accepted all year round

Funding Type

PhD Type

Integrin-mediated adhesions, such as podosomes and invadopodia, are the biophysical anchor to sense and to translate mechanobiological signals into various cellular events.
  (MRC DTP) Modelling inherited developmental ocular disorders using in vitro organoids to understand retinal stem cell fate decisions
  Dr Cerys Manning, Prof G Black
Application Deadline: 15 November 2019

Funding Type

PhD Type

Inherited developmental disorders account for much of childhood visual impairment. During early eye development stem cells must balance fate decisions between proliferation and differentiation at the same time as undergoing cell migration and morphogenesis to prevent such disorders.
  The functional characterization of the tumour suppressor gene CSMD1 in breast cancer
  Dr S Bell
Applications accepted all year round

Funding Type

PhD Type

CUB and Sushi multiple domains protein 1 (CSMD1) maps to 8p23, a region deleted in many cancers including breast cancer. Our previous work has established that CSMD1 is an independent prognostic marker in ductal breast cancer, with reduced expression associated with high tumour grade and poor survival1.
  Cutting off the fuel supply to calcium pumps in pancreatic cancer: a novel therapeutic strategy
  Dr J Bruce, Prof K Williams, Dr A P Gilmore
Applications accepted all year round

Funding Type

PhD Type

Background and Rationale. Pancreatic ductal adenocarcinoma (PDAC) has the poorest survival and limited treatment options. Therefore, the search for novel therapeutic targets and drugs designed to selectively kill PDAC cells must remain a central research strategy.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.